A leiomyosarcoma, especially in the early stages, may not be associated with any obvious symptoms other than irregular vaginal bleeding or feeling pressure in abdomen or pelvic.
Leiomyosarcomas are aggressive tumors that potentially cause complications due to metastasis to other organs, some of the complications of uterine leiomyosarcoma are include the following:[4][5][6][6][7][8][9]
The prognosis of leiomyosarcoma is poor and it depends upon different factors including site of tumor, size, and type, as well as the extent of tumor spread. Some patients with low grade tumors or with tumors that have not spread beyond stage I have better prognosis. In general, high-grade tumors that have spread widely throughout the body have less favorable survival rates. Some of these progostic factors that affect survival rates of patients with leiomyosarcoma include:[10]
FIGO stage at the time of the initial diagnosis (survival after initial diagnosis has been reported to be 50% in stage 1 and stage 2 disease)
↑Major FJ, Blessing JA, Silverberg SG, Morrow CP, Creasman WT, Currie JL, Yordan E, Brady MF (February 1993). "Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study". Cancer. 71 (4 Suppl): 1702–9. PMID8381710.
↑Gladdy, Rebecca A.; Qin, Li-Xuan; Moraco, Nicole; Agaram, Narasimhan P.; Brennan, Murray F.; Singer, Samuel (2013). "Predictors of Survival and Recurrence in Primary Leiomyosarcoma". Annals of Surgical Oncology. 20 (6): 1851–1857. doi:10.1245/s10434-013-2876-y. ISSN1068-9265.
↑Koivisto-Korander, Riitta; Butzow, Ralf; Koivisto, Anna-Maija; Leminen, Arto (2008). "Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: Experience in Helsinki University Central Hospital 1990–2001". Gynecologic Oncology. 111 (1): 74–81. doi:10.1016/j.ygyno.2008.06.002. ISSN0090-8258.
↑Keller, Nathan A.; Godoy, Heidi (2015). "Leiomyosarcoma of the Vagina: An Exceedingly Rare Diagnosis". Case Reports in Obstetrics and Gynecology. 2015: 1–4. doi:10.1155/2015/363895. ISSN2090-6684.
↑Hope, Isabel; Morton, Karen; Newlands, Carrie; Butler-Manuel, Simon; Madhuri, Thumuluru Kavitha (2017). "Lockjaw from a metastatic uterine leiomyosarcoma- case report and review of the literature". BMC Women's Health. 17 (1). doi:10.1186/s12905-017-0472-1. ISSN1472-6874.
↑Fleet, M.; Mellon, A.F.; Lee, J.A.; Talbot, D.; Eastham, E.J.; Pearson, A.D.J. (1994). "Duodenal leiomyosarcoma presenting with iron deficiency anemia". Journal of Pediatric Surgery. 29 (12): 1601–1603. doi:10.1016/0022-3468(94)90233-X. ISSN0022-3468.
↑Koivisto-Korander, Riitta; Butzow, Ralf; Koivisto, Anna-Maija; Leminen, Arto (2008). "Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: Experience in Helsinki University Central Hospital 1990–2001". Gynecologic Oncology. 111 (1): 74–81. doi:10.1016/j.ygyno.2008.06.002. ISSN0090-8258.